These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17614353)

  • 1. Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples.
    Nowatzke W; Woolf E
    AAPS J; 2007 Apr; 9(2):E117-22. PubMed ID: 17614353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key elements of bioanalytical method validation for small molecules.
    Bansal S; DeStefano A
    AAPS J; 2007 Mar; 9(1):E109-14. PubMed ID: 17408234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance.
    Savoie N; Garofolo F; van Amsterdam P; Bansal S; Beaver C; Bedford P; Booth BP; Evans C; Jemal M; Lefebvre M; Lopes de Silva AL; Lowes S; Marini JC; Massé R; Mawer L; Ormsby E; Rocci ML; Viswanathan C; Wakelin-Smith J; Welink J; White JT; Woolf E
    Bioanalysis; 2010 Dec; 2(12):1945-60. PubMed ID: 21110739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to calibration curves in bioanalysis.
    Brewer E; Bollin E
    Bioanalysis; 2009 Oct; 1(7):1201-8. PubMed ID: 21083046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
    Viswanathan CT; Bansal S; Booth B; DeStefano AJ; Rose MJ; Sailstad J; Shah VP; Skelly JP; Swann PG; Weiner R
    Pharm Res; 2007 Oct; 24(10):1962-73. PubMed ID: 17458684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in evaluation of bioanalytical method selectivity and drug stability.
    Dadgar D; Burnett PE
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):23-31. PubMed ID: 8833963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sponsor relationships, analyte stability in ligand-binding assays and critical reagent management: a bioanalytical CRO perspective.
    Lefor Bradford J
    Bioanalysis; 2015; 7(11):1337-46. PubMed ID: 26110706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations on ISR in multi analyte assays, QA/bioanalytical consultants and GCP by Global CRO Council for Bioanalysis (GCC).
    Sangster T; Maltas J; Struwe P; Hillier J; Boterman M; Doig M; Breda M; Garofolo F; Caturla MC; Couerbe P; Schiebl C; Pattison C; Goodwin L; Segers R; Garofolo W; Folguera L; Zimmer D; Zimmerman T; Pawula M; Tang D; Cox C; Bigogno C; Schoutsen D; de Boer T; Green R; Houghton R; Sable R; Siethoff C; Harter T; Best S;
    Bioanalysis; 2012 Jul; 4(14):1723-30. PubMed ID: 22877218
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment Methodology for Process Validation Lifecycle Stage 3A.
    Sayeed-Desta N; Pazhayattil AB; Collins J; Chen S; Ingram M; Spes J
    AAPS PharmSciTech; 2017 Jul; 18(5):1881-1886. PubMed ID: 27714700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC).
    Boterman M; Doig M; Breda M; Lowes S; Jersey J; Shoup R; Garofolo F; Dumont I; Martinez S; Needham S; Cruz Caturla M; Couerbe P; Guittard J; Maltas J; Lansing T; Bhatti M; Schiebl C; Struwe P; Sheldon C; Hayes R; Sangster T; Pattison C; Bouchard J; Goodwin L; Islam R; Segers R; Lin ZJ; Hillier J; Garofolo W; Zimmer D; Folguera L; Zimmermann T; Pawula M; Moussallie M; Teixeira Lde S; Rocha T; Tang D; Jardieu P; Truog J; Lin J; Lundberg R; Cox C; Breau A; Bigogno C; Schoutsen D; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Nicholson R; Jenkins R; Lin MH; Karnik S; De Boer T; Houghton R; Green R; DeMaio W; Sable R; Smith K; Siethoff C; Cojocaru L; Allen M; Harter T; Fatmi S; Sayyarpour F; Malone M; Best S; Fang X
    Bioanalysis; 2012 Mar; 4(6):651-60. PubMed ID: 22452256
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in validation, risk and uncertainty assessment of bioanalytical methods.
    Rozet E; Marini RD; Ziemons E; Boulanger B; Hubert P
    J Pharm Biomed Anal; 2011 Jun; 55(4):848-58. PubMed ID: 21237607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key elements of bioanalytical method validation for macromolecules.
    Kelley M; DeSilva B
    AAPS J; 2007 May; 9(2):E156-63. PubMed ID: 17614356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method validation in the bioanalytical laboratory.
    Buick AR; Doig MV; Jeal SC; Land GS; McDowall RD
    J Pharm Biomed Anal; 1990; 8(8-12):629-37. PubMed ID: 2100599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in Flow-Imaging Microscopy Measurements and Considerations for Biopharmaceutical Development.
    Rauk AP; Griffiths KL; Gossage MD; Weiss WF
    J Pharm Sci; 2016 Nov; 105(11):3296-3303. PubMed ID: 27663382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current industrial practices and regulatory requirements to assess analyte and reagent stability using ligand-binding assays.
    Wang J; Nowatzke W; Ma M
    Bioanalysis; 2015; 7(11):1371-84. PubMed ID: 26110710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design.
    Martin-Moe S; Lim FJ; Wong RL; Sreedhara A; Sundaram J; Sane SU
    J Pharm Sci; 2011 Aug; 100(8):3031-3043. PubMed ID: 21425164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a ligand-binding assay for active protein drug quantification following the 'free analyte QC concept'.
    Schick E; Staack RF; Haak M; Jordan G; Dahl U; Heinrich J; Birnboeck H; Papadimitriou A
    Bioanalysis; 2016 Dec; 8(24):2537-2549. PubMed ID: 27807984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do placebo based validation standards mimic real batch products behaviour? Case studies.
    Bouabidi A; Talbi M; Bouklouze A; El Karbane M; Bourichi H; El Guezzar M; Ziemons E; Hubert P; Rozet E
    J Pharm Biomed Anal; 2011 Jun; 55(3):583-90. PubMed ID: 21377822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICH M10 Bioanalytical Method Validation Guideline-1 year Later.
    Vazvaei-Smith F; Wickremsinhe E; Woolf E; Yu C
    AAPS J; 2024 Sep; 26(5):103. PubMed ID: 39266900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability: recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization Team.
    van de Merbel N; Savoie N; Yadav M; Ohtsu Y; White J; Riccio MF; Dong K; de Vries R; Diancin J
    AAPS J; 2014 May; 16(3):392-9. PubMed ID: 24550081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.